Evidence map›Paper›PMID 38504781›Full record

ArticleMolecular biology research communications2024

Association study of the polymorphisms rs2228611 of the

Zohra Touala-Chaila, Rym-Khadidja Abderrahmane, Slimane Kerroumi, Mostefa-Jamel Yousfi, Djebaria-Naima Meroufel, Abdallah Boudjema

Open access · greenAbstract read
In one paragraph

Article in Molecular biology research communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Investigation methylation status of tumor suppressor geneMolecular biology research communications · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Zohra Touala-ChailaUniversité Des Sciences Et de La Technologie d'Oran Mohamed-Boudiaf USTOMB El Mnaouar, BP 1505, Bir El Djir, 31000 Oran, Algerie. Laboratoire Génétique Moléculaire Et Cellulaire (LGMC) USTOMB.
Rym-Khadidja AbderrahmaneUniversité Des Sciences Et de La Technologie d'Oran Mohamed-Boudiaf USTOMB El Mnaouar, BP 1505, Bir El Djir, 31000 Oran, Algerie. Laboratoire Génétique Moléculaire Et Cellulaire (LGMC) USTOMB.
Slimane KerroumiEtablissement Hospitalier Universitaire d'Oran EHU 1 Novembre 1954, service Chirurgie Urologique, Oran, Algerie.
Mostefa-Jamel YousfiEtablissement Hospitalier Universitaire d'Oran EHU 1 Novembre 1954, service Chirurgie Urologique, Oran, Algerie.
Djebaria-Naima MeroufelUniversité Des Sciences Et de La Technologie d'Oran Mohamed-Boudiaf USTOMB El Mnaouar, BP 1505, Bir El Djir, 31000 Oran, Algerie. Laboratoire Génétique Moléculaire Et Cellulaire (LGMC) USTOMB.
Abdallah BoudjemaUniversité Des Sciences Et de La Technologie d'Oran Mohamed-Boudiaf USTOMB El Mnaouar, BP 1505, Bir El Djir, 31000 Oran, Algerie. Laboratoire Génétique Moléculaire Et Cellulaire (LGMC) USTOMB.
Université des Sciences et de la Technologie d'Oran Mohamed Boudiaf · DZUniversity Hospital of Oran · DZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bladder cancer (BC) is a multifactorial disease with a poorly understood main cause. In this study, we aimed to evaluate the effect of the polymorphisms rs2228611 of the DNMT1 gene and rs1569686 of the DNMT3B gene on the susceptibility to develop Bladder Cancer in the Algerian population. A case-control study design was adopted, with DNA samples of 114 BC patients and 123 healthy controls. We found that the rs2228611 of the DNMT1 gene was strongly associated with an increased risk of BC development under genetic models: Codominant AG

Indexed as

Bladder cancer (BC)DNMT1DNMT3Brs1569686rs2228611

Identifiers

PMID38504781
PMCPMC10946547
OpenAlexW4394767016

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.